M&A / Deals Avalyn seeks public debut to support new lung drug formulations pharminent April 24, 2026
M&A / Deals OZMOSI and Planview partner to enhance pharmaceutical data integration pharminent April 24, 2026
M&A / Deals BioAegis and Prenosis partner for inflammatory disease therapies pharminent April 22, 2026
M&A / Deals BioAegis and Prenosis partner for inflammatory disease therapies pharminent April 22, 2026
M&A / Deals Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs pharminent April 21, 2026
M&A / Deals Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout pharminent April 20, 2026
M&A / Deals Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal pharminent April 20, 2026
M&A / Deals Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions pharminent April 17, 2026
M&A / Deals Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions pharminent April 17, 2026
M&A / Deals Obesity’s explosive growth continues as Q1 deals exceed total 2025 value pharminent April 16, 2026
M&A / Deals Terremoto wins $108m in Series C to drive cancer and rare disease programmes pharminent April 16, 2026
M&A / Deals Beeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers pharminent April 15, 2026
M&A / Deals Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico pharminent April 15, 2026
M&A / Deals BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut pharminent April 15, 2026
M&A / Deals AbbVie enters world of pain in up to $715M deal with China’s Haisco pharminent April 13, 2026
